Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic

STOCKHOLM, May 22, 2023 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that they have submitted a Marketing Authorisation Application (MAA) for lecanemab, an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] (AD) with confirmed amyloid pathology in the brain, to the UK Medicines and Healthcare products … Read more

La 133e Foire de Canton rassemble les meilleurs équipements médicaux pour faire avancer le monde de la santé

GUANGZHOU, Chine, 22 mai 2023 /PRNewswire/ — Les questions de santé mondiale occupent le devant de la scène tandis que tous les pays se remettent de la pandémie de COVID-19. À mesure que le public devient plus vigilant au sujet de sa santé, les établissements médicaux intensifient également leurs efforts en fournissant des services et … Read more

Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102

SHANGHAI and WARREN, N.J. , May 21, 2023 /PRNewswire/ — Laekna, a clinical-stage biotechnology company dedicated to bringing novel therapies to cancer and liver fibrosis patients worldwide, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of LAE102 antibody to initiate clinical development. This is Laekna’s first … Read more

End of life: the future law will have to ensure “traceability from A to Z”, according to Firmin Le Bodo

the essential “We must ensure traceability from A to Z (…) For medico-legal reasons of course. But also to establish how many people have had access to this new right each year and under what conditions”, explained the minister delegate, Agnès Firmin le Bodo, in an interview with the Journal du Dimanche. The future bill … Read more